JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

VEGFR

A8236 Regorafenib
4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A5760 KRN 633

Summary: VEGFR inhibitor,ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥13.75 mg/mL
A5467 Ponatinib (AP24534)
1 Citation

Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src

Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor

≥53.3 mg/mL
A5331 TSU-68 (SU6668,Orantinib)

Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive

insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
A5017 Motesanib Diphosphate (AMG-706)

Summary: VEGFR/ PDGFR/c-Kit/Ret inhibitor

≥28.45 mg/mL
A3969 Vatalanib
1 Citation

Target: VEGFR

Summary: VEGFR-1/-2 inhibitor,cell-permeable

≥16.85 mg/mL
A3906 Vandetanib hydrochloride

Summary: VEGFR/EGFR inhibitor

≥51.2 mg/mL
A3870 TG 100801

Target: VEGFR|FGFR|Src|Fyn kinase

Summary: Multi-kinase inhibitor

Soluble in DMSO
A3847 SU5416
7 Citation

Target: VEGFR

Summary: VEGFR2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL